N
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
Ireland
Recent Filings
- 10-Q4.5 MBNabriva Therapeutics plcOct 18, 5:57 PM ET·0001558370-23-016524
- 8-K853.3 KBNabriva Therapeutics plcJul 31, 8:07 AM ET·0001104659-23-085605
- 8-K199.8 KBNabriva Therapeutics plcJul 24, 9:00 AM ET·0001104659-23-083250
- 8-K507.6 KBNabriva Therapeutics plcJul 7, 4:34 PM ET·0001104659-23-079156
- 8-K199.4 KBNabriva Therapeutics plcJun 1, 4:30 PM ET·0001104659-23-067071
- 10-Q5.6 MBNabriva Therapeutics plcMay 22, 4:01 PM ET·0001558370-23-010302
- 10-K11.9 MBNabriva Therapeutics plcApr 17, 4:15 PM ET·0001558370-23-006062
- 8-K236.1 KBNabriva Therapeutics plcFeb 3, 8:45 PM ET·0001104659-23-010788
- 8-K500.6 KBNabriva Therapeutics plcJan 20, 6:00 AM ET·0001104659-23-005144
- 8-K259.6 KBNabriva Therapeutics plcJan 9, 4:13 PM ET·0001104659-23-002268
Insiders
10- Bolte AxelDirector
- Bourdow Carrie L.Director
- Broom Colin MDChief Executive Officer
- BURGESS DANIEL DDirector
- CORRIGAN MARKDirector
- Crotty RobertGeneral Counsel & Corp Sec.
- Dalton LisaDirector
- Dolan DanielChief Financial Officer
- Gelone Steven P.Chief Development Officer
- Guico-Pabia Christine J.Chief Medical Officer
Tickers
No tickers on record
Addresses
business
25-28 NORTH WALL QUAY
DUBLIN, L2, D01 H104
mailing
414 COMMERCE DRIVE STE 120
FORT WASHINGTON, PA, 19034
Former Names
- Nabriva Therapeutics AG2017-07-10